Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group Cigna Corp stake
total: 111
Kahn Brothers Group CI trades
- Total transactions:
- 6
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 3
- Held since:
- 2024 Q1
- Held for:
- 5 quarters
- Latest activity:
- 2025 Q2
According to 2026 Q2 report, Kahn Brothers Group doesn't hold any Cigna Corp (CI) shares. To date, the estimated cost basis is nearly $358.51 for "buy" trades and estimated average "sell" price is $472.92. Kahn Brothers Group first purchased CI in 2024 Q1, initially acquiring 1,101 shares. Since the initial investment in Cigna Corp (CI), Kahn Brothers Group has made 5 more transactions.
When did Kahn Brothers Group sell Cigna Corp (CI)?
Kahn Brothers Group sold off the entire Cigna Corp (CI) position in 2025 Q2.
When did Kahn Brothers Group buy Cigna Corp (CI)?
Kahn Brothers Group first invested in Cigna Corp (CI) in 2024 Q1 at the reported quarter-end price of $363.60 per share.
What's the cost basis of Kahn Brothers Group's CI stake?
The estimated cost basis for Cigna Corp (CI) stake is around $358.51 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $358.51
- Weighted AVG sell price:
- $472.92
Kahn Brothers Group's historical trades in Cigna Corp
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q2
|
0.00%
|
0
|
$329.00
|
|
-100% (-841)
|
-0.06%
|
|
2025 Q1
|
0.06%
|
841
|
$329.00
|
$276,689
|
-4.86% (-43)
|
-0%
|
|
2024 Q4
|
0.05%
|
884
|
$275.72
|
$243,740
|
-6.06% (-57)
|
-0%
|
|
2024 Q3
|
0.06%
|
941
|
$346.44
|
$325,999
|
+97.69% (+465)
|
+0.03%
|
|
2024 Q2
|
0.06%
|
476
|
$694.47
|
$330,570
|
-56.77% (-625)
|
-0.06%
|
|
2024 Q1
|
0.06%
|
1,101
|
$363.60
|
$400,326
|
new
|
+0.06%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.